Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers. - Test2 - elhamkhani - TriplyDB

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.

http://www.wikidata.org/entity/Q37708274

about

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays.

P2860

Q26852535-FE04CBB1-09B7-442D-B190-83DF4D41B803 Q47834734-813354BB-8D4D-4F46-B808-027BF6C04333

P2860

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.

http://www.wikidata.org/entity/Q37708274

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.

@en

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.

@nl

type

label

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.

@en

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.

@nl

prefLabel

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.

@en

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.

@nl

P1433

Q37708274-672A4211-A03E-48D5-B7F2-016F1F71D0E1

P1476

Q37708274-89EF398C-CB41-487D-A10E-D5CCB5D2F0D7

P2093

Q37708274-0363B630-FE35-4D31-AF3C-B35261721FFD

Q37708274-6859CF05-E7EE-4ADC-AA72-7C6CB7F89588

Q37708274-AB533F18-A945-4004-BC0B-C4FCD2BCFCD4

P2860

Q37708274-242A54F0-9E16-4873-A764-A19824C1C5AF

Q37708274-2B662DF2-050B-48A3-A365-9F3A9951F610

Q37708274-2CC30D21-7FC1-4D3C-8B5A-C2F6DAE7639F

Q37708274-35C83118-A213-422E-8398-F4B7ABDA9A5E

Q37708274-535BB698-CB3F-467C-AC94-A74E3B4397BF

Q37708274-5D3A9A36-D4C1-4200-B4B8-FC7C8C2897A5

Q37708274-7BB0BC09-624F-4FFD-A9FC-3FFB3B98FB77

Q37708274-80CF34B5-9723-4833-9688-4F868284F7AC

Q37708274-97AD6E72-4A7F-4FF7-A3FB-C0FF713CB914

Q37708274-A134B894-3569-4443-B02F-AA5B1AAF9912

P304

Q37708274-18B073D4-4081-4BCD-AFBE-3CECBA9949E1

P31

Q37708274-883E5F50-3BEA-4E04-8BB5-FDB067E9D105

P356

Q37708274-27A34951-245D-4515-B786-BDF82DA76E41

P433

Q37708274-84D7A0CA-2832-4DEC-A15B-73292BDAF0D3

P478

Q37708274-C3E89932-89B5-4227-9820-916F85E5A9A9

P50

Q37708274-1EFC652F-11D2-48E1-B638-44CB4D5EFA79

Q37708274-738BD220-3B9C-4519-AB5B-3C0E97796053

P577

Q37708274-C95537D2-87FA-4A90-BA09-310BFC2137AF

P5875

Q37708274-245CCBAA-CA59-4C14-AC32-D45433E5DD19

P698

Q37708274-9F8310CF-AD82-437D-A09E-C4883249F2D1

P921

Q37708274-76581AA4-8BC0-44FA-8580-99F5C8551116

P932

Q37708274-994882F3-C0F1-494A-9C3D-33B27DBFA416

P356

YMJ.2014.55.3.683

P1433

Yonsei Medical Journal

P1476

Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers

@en

P2093

Jong-Youn Kim

http://www.w3.org/2001/XMLSchema#string

Young Dae Kim

http://www.w3.org/2001/XMLSchema#string

Young-Won Yoon

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review.

Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.

Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.

Cytochrome P450 2C19 polymorphism is associated with reduced clopidogrel response in cerebrovascular disease.

The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention.

Stenting versus aggressive medical therapy for intracranial arterial stenosis.

P304

683-688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2014.55.3.683

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261521164

http://www.w3.org/2001/XMLSchema#string

P698

24719135

http://www.w3.org/2001/XMLSchema#string

P921

P932

3990098

http://www.w3.org/2001/XMLSchema#string